AUPH
Price
$8.19
Change
+$0.10 (+1.24%)
Updated
Jun 6 closing price
Capitalization
1.09B
54 days until earnings call
NAMS
Price
$20.14
Change
+$0.63 (+3.23%)
Updated
Jun 6 closing price
Capitalization
2.19B
66 days until earnings call
Interact to see
Advertisement

AUPH vs NAMS

Header iconAUPH vs NAMS Comparison
Open Charts AUPH vs NAMSBanner chart's image
Aurinia Pharmaceuticals
Price$8.19
Change+$0.10 (+1.24%)
Volume$911.77K
Capitalization1.09B
NewAmsterdam Pharma
Price$20.14
Change+$0.63 (+3.23%)
Volume$1.01M
Capitalization2.19B
AUPH vs NAMS Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. NAMS commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a StrongBuy and NAMS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (AUPH: $7.98 vs. NAMS: $17.31)
Brand notoriety: AUPH and NAMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 87% vs. NAMS: 64%
Market capitalization -- AUPH: $1.09B vs. NAMS: $2.19B
AUPH [@Biotechnology] is valued at $1.09B. NAMS’s [@Biotechnology] market capitalization is $2.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileNAMS’s FA Score has 1 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • NAMS’s FA Score: 1 green, 4 red.
According to our system of comparison, both AUPH and NAMS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 5 TA indicator(s) are bullish while NAMS’s TA Score has 4 bullish TA indicator(s).

  • AUPH’s TA Score: 5 bullish, 4 bearish.
  • NAMS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than NAMS.

Price Growth

AUPH (@Biotechnology) experienced а -4.32% price change this week, while NAMS (@Biotechnology) price change was -6.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

AUPH is expected to report earnings on Jul 31, 2025.

NAMS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($2.19B) has a higher market cap than AUPH($1.09B). AUPH YTD gains are higher at: -11.136 vs. NAMS (-32.646). AUPH has higher annual earnings (EBITDA): 31.7M vs. NAMS (-241.49M). NAMS has more cash in the bank: 834M vs. AUPH (358M). NAMS has less debt than AUPH: NAMS (448K) vs AUPH (79.4M). AUPH has higher revenues than NAMS: AUPH (235M) vs NAMS (45.6M).
AUPHNAMSAUPH / NAMS
Capitalization1.09B2.19B50%
EBITDA31.7M-241.49M-13%
Gain YTD-11.136-32.64634%
P/E Ratio29.94N/A-
Revenue235M45.6M515%
Total Cash358M834M43%
Total Debt79.4M448K17,723%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHNAMS
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
76%
Bullish Trend 11 days ago
55%
Momentum
ODDS (%)
Bullish Trend 11 days ago
84%
Bearish Trend 11 days ago
43%
MACD
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 11 days ago
41%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 11 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 11 days ago
53%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 19 days ago
71%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
Bearish Trend 12 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
58%
Aroon
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 11 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with CMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
-2.09%
CMRX - AUPH
38%
Loosely correlated
N/A
SHJBF - AUPH
38%
Loosely correlated
N/A
KRYS - AUPH
37%
Loosely correlated
-2.44%
CRDF - AUPH
37%
Loosely correlated
+2.90%
SCPH - AUPH
36%
Loosely correlated
+1.13%
More

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+1.76%
QURE - NAMS
52%
Loosely correlated
-2.97%
CMRX - NAMS
49%
Loosely correlated
N/A
CRDF - NAMS
39%
Loosely correlated
+2.90%
BEAM - NAMS
37%
Loosely correlated
-0.88%
AUPH - NAMS
35%
Loosely correlated
-2.09%
More